id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2017-0004-0005,DEA,DEA-2017-0004,Schedules of Controlled Substances: Temporary Placement of 4-Fluoroisobutyryl Fentanyl into Schedule I,Rule,,2017-05-03T04:00:00Z,2017,5,,,2017-05-03T13:05:10Z,2017-08943,0,0,090000648258d274
DEA-2017-0004-0001,DEA,DEA-2017-0004,Schedules of Controlled Substances: Temporary Placement of 4-Fluoroisobutyryl Fentanyl into Schedule I,Proposed Rule,,2017-03-23T04:00:00Z,2017,3,,,2017-03-23T13:53:51Z,2017-05728,0,0,090000648251fac5
DEA-2017-0004-0002,DEA,DEA-2017-0004,3Factor 4-fluoroisobutyryl fentanyl,Supporting & Related Material,,2017-03-23T04:00:00Z,2017,3,,,2017-03-23T13:48:02Z,,0,0,090000648252025f
DEA-2017-0004-0003,DEA,DEA-2017-0004,SIGNED Letter-4-fluoroisobutyryl fentanyl letter to HHS,Supporting & Related Material,,2017-03-23T04:00:00Z,2017,3,,,2017-03-23T13:52:26Z,,0,0,090000648251feb6
DEA-2017-0004-0004,DEA,DEA-2017-0004,HHS response,Supporting & Related Material,,2017-03-23T04:00:00Z,2017,3,,,2017-03-23T13:53:16Z,,0,0,090000648251fec4